Pfizer, the values of Integrity, Leadership, Innovation, Performance,

Pfizer, Pharmaceutical Company Key StrengthsOne of the main strengths of Pfizer is that it is one of the world largest and most profitable pharmaceutical company with over 150 years of experience in Research & Development. Another strength of Pfizer is it has over 100,000 employees. Also, Pfizer brand name is very strong and has a global recall. Pfizer dedicate themselves to humanity’s quest for longer, healthier, happier lives through innovation in pharmaceutical, consumer, and animal health products. To achieve this purpose and mission, Pfizer affirm the values of Integrity, Leadership, Innovation, Performance, Teamwork, Customer Focus, Respect for People and Community. (Pfizer.

com)Strengths of Pfizer Large size leading to economies of scale. Strong presence in the vaccines and biologics market following Wyeth’s acquisition. Pfizer’s product pipeline currently consists of 82 projects at different stages of development. Mergers and acquisitions with big pharma brands increasing brand reputation. Wide range of products (over 247 drugs only in the United States). Well developed distribution channels.

We Will Write a Custom Essay Specifically
For You For Only $13.90/page!

order now

Using technology in improving customer relationship and business efficiency. Key WeaknessPfizer’s main weakness lies in its strong reliance on the blockbuster portfolio that generates almost a half of the overall sales. Another weakness is the negative brand image due to involvement in largest healthcare fraud of marketing its drug illegally.

Also, discontinuation of products in the latter stages of development. Weakness of Pfizer Inadequate infrastructure for fermentation-based drug remedies and effluent treatment plants. Limited emission right. Overdependence on blockbuster drugs. Lack of or inadequate subsidies and fiscal incentives for the industry.

Marketing with other companies and merging with other pharmaceuticals can halter its global popularity. Tough competition from other major pharma brands means limited scope for market share growth.